Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.

Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.

Item
http://www.wikidata.org/entity/Q34387990
Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinomaOverexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cellsProteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cellsConsortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.A second target of benzamide riboside: dihydrofolate reductaseQuantitative evaluation of vimentin expression in tumour stroma of colorectal cancerLncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients.Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells.Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance.Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristineA Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic
P2860

Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells.

Item
http://www.wikidata.org/entity/Q34387990
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@ast
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@en
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@nl
type
label
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@ast
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@en
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@nl
prefLabel
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@ast
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@en
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Modulation of IMPDH2, survivin ...... HT29 human colon cancer cells.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1742-4658.2004.04504.X
P407
P433
P478
P50
P577
P5875
P698